Covidien Acquires Scandius Biomedical Inc.

Biotech Week via NewsEdge Corporation :

2007 NOV 28 - (NewsRx.com) -- Covidien Ltd. (NYSE: COV, BSX: COV), a leading global provider of healthcare products, announced that one of its subsidiaries has acquired Scandius Biomedical Inc., a developer of devices for sports-related surgeries. Financial terms were not disclosed (see also Biomedicine).
Located in Littleton, MA, Scandius Biomedical uses a network of distributors to sell proprietary products for arthroscopic reconstruction of the Anterior Cruciate Ligament (ACL): the Stratis(R) ST Femoral Fixation System and the TriTis(R) Tibial Fixation System. The systems consist of instrumentation and both non-absorbable and bioabsorbable polymer implants.

read the full article: http://www.devicelink.com/newsedge/